Stay updated with breaking news from Cell Model. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Coave Therapeutics (‘Coave’), a genetic medicine company focused on developing life-changing therapies, is delighted to announce that it is one of six organisations sharing $2.9 million in grants from the ALS Association that support the advancement of novel therapies for the treatment of amyotrophic lateral ...
![[Full text] Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is - Vimarsana News](https://vimarsana.com/images/vimarsana-bigimage.jpg)
XYS Activates the PI3K/Akt Pathway Network pharmacology suggested that the PI3k/Akt pathway was the main mechanism of action in IS treatment by XYS. Therefore, we evaluated the effect of XYS on the mRNA and protein expression of PI3k and Akt in PC12 cells. OGD/R inhibited mRNA expression of PI3K and Akt significantly in PC12 cells (Figures 9 and 10). Compared with the normal group, although protein expression of PI3K and Akt did not change significantly, phosphorylation of PI3K and Akt was inhibited significantly. Fortunately, XYS therapy could reverse this inhibition. These results indicated...